The FDA authorized the use of an experimental antibody treatment for Covid-19

The FDA authorized the use of an experimental antibody treatment for Covid-19

Amid record levels of new Covid-19 infections and hospitalizations, the Food and Drug Administration announced on Saturday that this would allow emergency use drug therapy called an antibody RAIN-COV2 which helps the immune system fight the virus. The treatment, developed by biotech company Regeneron, consists of two antibodies called casirivimab and imdevimab which have so … Read more